Salk Institute

Technologies Available for Licensing

Pluripotent Stem Cells from Neuronal Cells

Inventors: Maria C. N. Marchetto, Alysson R. Muotri & Fred H. Gage
Potential Uses: CNS, Drug Discovery, Gene Expression, Research Tool, Stem Cells

Figure 1. Schematic model of virus-free human iPS generation from neural stem cells

Genetic reprogramming of somatic cells to a pluripotent state (induced pluripotent stem or iPS cells) by over-expression of specific genes has been accomplished using mouse and human cells. Resultant iPS cells are isogenic to the donor individual, i.e., carrying similar genetic background, and are useful for a potential therapeutic purpose with lower risk of immune rejection as well as applicable to understand complex diseases with heritable and sporadic conditions.

Currently, there are several obstacles before iPS cells might be considered for cellular therapy, such as the use of oncogenes and insertional mutagenesis by delivery viruses that may induce malignant cell transformation. Here we describe the generation of human iPS cells without viral vectors and the first transcriptional profile of a "footprint-free" iPS cells. Pluripotent factors Oct4 and Nanog were cloned in episomal vectors and transfected into Sox2 and c-Myc expressing human fetal neural progenitor cells. The transient expression of these two factors resulted in highly efficient generation of human iPS cells without evidence of vector integration. Our method represents a safe way to generate human iPS cells for clinical purposes and basic research.

Salk No: S08017
Patent Status: U.S. Patent Application Filed March 2009
Publications: PLoS ONE 4(9): e7076 (September 2009)
License Terms: Exclusive, Partially Exclusive, Nonexclusive license negotiable
Contact: Michelle Booden, Ph.D., Director of Licensing, 858.453.4100 x1612,

Get Involved

Sign up for our email newsletter

Fill out my online form.
Salk Institute for Biological Studies
Street: 10010 N Torrey Pines Rd
City: La Jolla, CA 92037
Phone: 858.453.4100
Charity Navigator Rating
  • Salk Twitter
  • Salk LinkedIn
  • Salk Facebook
  • Salk Instagram
  • Salk Google+
  • Salk YouTube
  • Salk RSS Feed
© Copyright 2015 Salk Institute for Biological Studies | Privacy Policy About Scientists & Research News & Media Events Support